Is registration required for the symposium?

Yes, please register on this page. Attendance is free of charge for qualified biotech and pharma R&D professionals.

Is this a technical seminar or presentation?

Yes. The symposium includes scientific presentations on bioanalysis, biomarkers, immunogenicity, and clinical pharmacology, followed by a panel discussion and an executive networking reception.

Who should attend this symposium?

Clinical pharmacology and pharmacometrics leaders, bioanalytical and biomarker scientists, translational medicine and DMPK professionals, clinical development and operations leaders, and senior scientists across biotech and biopharma organizations.

What topics will be covered?

Integrated bioanalysis across drug modalities, immunogenicity and neutralizing antibody assessment, ADC bioanalysis, biomarker strategy, model-informed drug development, and dose optimization.

Is there a networking component?

Yes. The symposium includes networking during lunch and breaks, and concludes with an executive networking reception and happy hour at the same venue.

Oct 12, 2026

18th Annual Immunogenicity & Bioassay Summit

Visit Crystal Bio Solutions at Booth #4, 18th Annual Immunogenicity & Bioassay Summit, to explore partnerships that advance biologics development.

Event Details

Crystal Bio Solutions is joining 18th Annual Immunogenicity & Bioassay Summit, connecting with FDA, industry, and academic experts to discuss immunogenicity risk assessment, bioassay development, and clinical strategies supporting biologics and other emerging modalities.

Date: September 15 to 16, 2026

Booth Number: 67b

Location: Westin Alexandria Old Town, 400 Courthouse Square, Alexandria, VA

To schedule a meeting:

cbs_bd@crystalpharmatech.com

Who Will You Meet

Ye Gu, Ph.D.

Head of US BD and CTO for Biologics

Allan Cortes

Head of West Coast Business

What Will We Discuss

Bioanalysis & Biomarkers Expert-driven, GLP-compliant bioanalysis and biomarker solutions built for diverse modalities and innovative pipelines.

Quantitative Clinical Pharmacology We provide strategic insight backed by robust data gathering and interpretation, to accelerate decision-making from IND to NDA.

These discussions are exploratory. Formal project scoping or regulatory advice requires structured engagement and confidentiality agreements.

18th Annual Immunogenicity & Bioassay Summit

Event Details

Who Will You Meet

What Will We Discuss

Register Below